Translational Oncology Research International

TRIO-US also provides protocol development and project management services for investigator initiated trials to be conducted at UCLA and/or the TRIO-US Network. The TRIO-US Network consists of more than 15 community oncology practices across multiple states, a majority in Southern California, responsible for executing clinical trials brought to the... m by the UCLA Clinical Research Unit (CRU). Many of the TRIO-US Network sites have participated in clinical trials with UCLA since the inception of the network over 20 years ago. UCLA provides the TRIO-US administrative staff with central study activities including regulatory, pharmacy, contracts and billing. TRIO, a not-for-profit organization, is a global leader in translational oncology research through scientific innovation, excellence in trial development and execution, and collaboration with investigators and industry. TRIO has three values which the organization follows: integrity, teamwork and passion. The ultimate goal is to improve the survival and quality of life of patients with cancer. TRIO consists of three research partners: UCLA-Translational Oncology Research Laboratory (UCLA-TORL) Translational Research In Oncology-United States Network (TRIO-US) Translational Research In Oncology-Global (TRIO-Global) The 2 clinical research entities of TRIO are managed by a single Board of Directors (BOD) which meets twice annually. The collaboration between the three organizations began in 1999 when a UCLA faculty member proposed a series of clinical trial designs to TRIO-Global based on basic and preclinical science findings from his laboratory. Two pilot studies and three international trials incorporating these findings were launched and conducted by TRIO-Global and the TRIO-US Network. UCLA-TORLRead More